Research and Markets: Looking at Bioinformatics - IT's Human Touch - Updated 2013 Report

DUBLIN--(BUSINESS WIRE)--April 17, 2013-- 

Research and Markets has announced the addition of the "Looking at Bioinformatics - IT's Human Touch" report to their offering.

Aruvian's R'search's report - Looking at Bioinformatics - IT's Human Touch - is a analytical docket on the Bio Informatics services sector and explains the concept of this IT activity which is revolutionizing the manner in which drugs are discovered and developed globally. The report provides an insight into the market activity currently underway at major global markets and the expanding prospects of Bioinformatics in these markets which is providing thrust to drug research in these markets.

The changing face of today's marketplace is majorly energized and made possible by the support and impetus of IT and it's applications across wide ranging industries and research applications. The growing acceptance of Bioinformatics as an important field requiring focused commercial support and activity has become a pre-requisite for firms depending on development & discovery of new drugs for patented drug solutions.

The advent of Bioinformatics was initiated in the industry by firms which had the foresight to establish the high core strength of this tool in gene sequencing etc where conventional methods would take years of documented research beyond the capacity purview of today's drug firms which need to identify market opportunities and respond to the same with certified clinical results with increased speed. The role of Bioinformatics in Human Genome and other projects provides a vital, powerful tool in the hands of researchers who need accurate data in order to develop specific drug solutions and also achieve such results in time bound budget programs.

The market of Bioinformatics is moving towards joint development programs and exploring synergetic cost sharing initiatives thereby driving consolidation in the industry which is together identifying newer opportunities in order to expand the service bases.

Key Topics Covered:

A. Executive Summary

B. Bioinformatics Market Concept

C. Bioinformatics Market Consumers

D. Key Factors Responsible for the Development of Bioinformatics

E. Challenges in the Implementation of Bioinformatics

F. Intensive Activity Markets

G. Industry Cost Pie

H. Major Industry Contributors

   -- H.1 Accelrys 
 
   -- H.2 Amersham Biosciences Limited 
 
   -- H.3 Applied Biosystems Group 
 
   -- H.4 Celera Genomics 
 
   -- H.5 Cengent Therapeutics Inc. 
 
   -- H.6 Compugen Ltd. 
 
   -- H.7 Incyte Corporation 
 
   -- H.8 LION Bioscience AG 

I. Bioinformatics Market - Future Perspective

J. Appendix

K. Glossary of Terms

For more information visit Research and Markets

 
    CONTACT: Research and Markets 

Laura Wood, Senior Manager.

press@researchandmarkets.com

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Sector: Bioinformatics

 
    SOURCE: Research and Markets 
Copyright Business Wire 2013